Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 3 (neurula)
Damuth DL et al. (2024)
|
Xla Wt + Xla.sox21.S
NF15 (RT-PCR)
|
|
|
|
Fig 2 C abcd
Bou-Rouphael J et al. (2024)
|
Xla Wt + barhl1
NF45 (in situ hybridization)
|
|
|
|
Fig S3 C
Bou-Rouphael J et al. (2024)
|
Xla Wt + barhl1 MO
NF41-42 (in situ hybridization)
|
|
|
|
Fig 3 A a' a""B C D a
Bou-Rouphael J et al. (2024)
|
Xla Wt + barhl1 MO
NF45 (in situ hybridization)
|
|
|
|
Fig. S3 D
Bou-Rouphael J et al. (2024)
|
Xla Wt + barhl1 MO
NF48 (in situ hybridization)
|
|
|
|
Fig 2 A a a' a'', b b' b'', c; B abcd
Bou-Rouphael J et al. (2024)
|
Xla wt +tcf7l1-delta_ctnnb1-GR
NF45 (in situ hybridization)
|
|
|
|
Fig. 3D
Yamamoto T et al. (2023)
|
Xla Wt + hs6st1 CRISPR
NF33/34 (in situ hybridization)
|
|
|
|
Fig. 2. C-M
Edwards-Faret G et al. (2021)
|
Xla Wt + spinal cord amputation
NF50 + 2 dpt ( immunohistochemistry)
|
|
|
|
Fig. 10 C col 2
Sullivan CH et al. (2019)
|
Xla Wt + irx1
NF 24- NF 28 (in situ hybridization)
|
|
|
|
Fig. 10 D col 2
Sullivan CH et al. (2019)
|
Xla Wt + irx1 + Six1 MO
NF 24- NF 28 (in situ hybridization)
|
|
|